Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML.
Saved in:
| Title: | Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML. |
|---|---|
| Authors: | Basheer F; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK., Giotopoulos G; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK., Meduri E; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK., Yun H; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK., Mazan M; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Wellcome Trust Sanger Institute, Hinxton, UK., Sasca D; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK., Gallipoli P; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK., Marando L; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK., Gozdecka M; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Wellcome Trust Sanger Institute, Hinxton, UK., Asby R; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK., Sheppard O; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK., Dudek M; Wellcome Trust Sanger Institute, Hinxton, UK., Bullinger L; Charité University Hospital, Berlin, Germany., Döhner H; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Dillon R; Department of Medical and Molecular Genetics, Kings College School of Medicine, UK., Freeman S; Department of Clinical Immunology, University of Birmingham Medical School, Edgbaston, Birmingham, UK., Ottmann O; Department of Haematology, University of Cardiff, Cardiff, UK., Burnett A; Isle of Arran, UK., Russell N; Department of Haematology, University of Nottingham, Nottingham, UK., Papaemmanuil E; Departments of Epidemiology and Biostatistics and Cancer Biology, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY., Hills R; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Campbell P; Wellcome Trust Sanger Institute, Hinxton, UK., Vassiliou GS; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust Sanger Institute, Hinxton, UK., Huntly BJP; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK bjph2@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK. |
| Source: | The Journal of experimental medicine [J Exp Med] 2019 Apr 01; Vol. 216 (4), pp. 966-981. Date of Electronic Publication: 2019 Mar 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30890554 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Basheer+F%22">Basheer F</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Giotopoulos+G%22">Giotopoulos G</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Meduri+E%22">Meduri E</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Yun+H%22">Yun H</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Mazan+M%22">Mazan M</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Sasca+D%22">Sasca D</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Gallipoli+P%22">Gallipoli P</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Marando+L%22">Marando L</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Gozdecka+M%22">Gozdecka M</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Asby+R%22">Asby R</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Sheppard+O%22">Sheppard O</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Dudek+M%22">Dudek M</searchLink>; Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Bullinger+L%22">Bullinger L</searchLink>; Charité University Hospital, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Döhner+H%22">Döhner H</searchLink>; Department of Internal Medicine III, University of Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Dillon+R%22">Dillon R</searchLink>; Department of Medical and Molecular Genetics, Kings College School of Medicine, UK.<br /><searchLink fieldCode="AU" term="%22Freeman+S%22">Freeman S</searchLink>; Department of Clinical Immunology, University of Birmingham Medical School, Edgbaston, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Ottmann+O%22">Ottmann O</searchLink>; Department of Haematology, University of Cardiff, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Burnett+A%22">Burnett A</searchLink>; Isle of Arran, UK.<br /><searchLink fieldCode="AU" term="%22Russell+N%22">Russell N</searchLink>; Department of Haematology, University of Nottingham, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Papaemmanuil+E%22">Papaemmanuil E</searchLink>; Departments of Epidemiology and Biostatistics and Cancer Biology, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan-Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Hills+R%22">Hills R</searchLink>; Nuffield Department of Population Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Campbell+P%22">Campbell P</searchLink>; Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Vassiliou+GS%22">Vassiliou GS</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust Sanger Institute, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Huntly+BJP%22">Huntly BJP</searchLink>; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK bjph2@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK.; Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985109R%22">The Journal of experimental medicine</searchLink> [J Exp Med] 2019 Apr 01; Vol. 216 (4), pp. 966-981. <i>Date of Electronic Publication: </i>2019 Mar 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Rockefeller+University+Press%22">Rockefeller University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2985109R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1540-9538 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221007%22">00221007 </searchLink><i>NLM ISO Abbreviation: </i>J Exp Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30890554 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1084/jem.20181276 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 966 Titles: – TitleFull: Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Basheer F – PersonEntity: Name: NameFull: Giotopoulos G – PersonEntity: Name: NameFull: Meduri E – PersonEntity: Name: NameFull: Yun H – PersonEntity: Name: NameFull: Mazan M – PersonEntity: Name: NameFull: Sasca D – PersonEntity: Name: NameFull: Gallipoli P – PersonEntity: Name: NameFull: Marando L – PersonEntity: Name: NameFull: Gozdecka M – PersonEntity: Name: NameFull: Asby R – PersonEntity: Name: NameFull: Sheppard O – PersonEntity: Name: NameFull: Dudek M – PersonEntity: Name: NameFull: Bullinger L – PersonEntity: Name: NameFull: Döhner H – PersonEntity: Name: NameFull: Dillon R – PersonEntity: Name: NameFull: Freeman S – PersonEntity: Name: NameFull: Ottmann O – PersonEntity: Name: NameFull: Burnett A – PersonEntity: Name: NameFull: Russell N – PersonEntity: Name: NameFull: Papaemmanuil E – PersonEntity: Name: NameFull: Hills R – PersonEntity: Name: NameFull: Campbell P – PersonEntity: Name: NameFull: Vassiliou GS – PersonEntity: Name: NameFull: Huntly BJP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2019 Apr 01 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1540-9538 Numbering: – Type: volume Value: 216 – Type: issue Value: 4 Titles: – TitleFull: The Journal of experimental medicine Type: main |
| ResultId | 1 |